The Cystatin C Digest: Feb 2021 Study Summary

11. Mar 2021 | 3 min read

The Cystatin C Digest: Feb 2021 Study Summary

Gentian Cystatin C Digest - Study summary

In recognition of #KidneyMonth, Gentian has launched the cystatin C digest webinar series, in which we will summarise some of the exceptional and new research being conducted on the clinical use of Cystatin C.

In this first segment, we will present these three studies:

    1. Liu W et al. Predictive Value of Serum Creatinine/Cystatin C in Acute Ischemic Stroke Patients under Nutritional Intervention. J Nutr Health Aging, 2021. 25(3): p. 335-339.

    2. Mahmoud AA et al. Assessment of Subclinical Renal Glomerular and Tubular Dysfunction in Children with Beta Thalassemia Major. Children (Basel), 2021. 8(2).

    3. Akpinar K, D Aslan, and SM Fenkci. Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy. J Bras Nefrol, 2021.

Watch webinar here

 

HubSpot Video

 OR WATCH ON YOUTUBE HERE

 

Contact us

Interested in cystatin C? To find out more, send us an email marketing@gentian.com or fill out the form below:

 

Cystatin C immunoassay brochure

You may also read


Meet us in 2023 - Conferences & Exhibitions

Jan 27, 2023

Meet us in 2023 - Conferences & Exhibitions

Meet us in 2023 We will attend several trade shows, conferences and exhibitions in 2023. Here are some of the..

IVDR-certified: Cystatin C and GCAL® (Plasma and serum calprotectin)

Jan 13, 2023

IVDR-certified: Cystatin C and GCAL® (Plasma and serum calprotectin)

Committing to the new European Union (EU) quality and safety standards To ensure continuous compliance for..

GCAL® - Plasma and serum calprotectin in routine use

Dec 15, 2022

GCAL® - Plasma and serum calprotectin in routine use

Clinical value: Plasma and serum calprotectin Calprotectin in blood shows significant diagnostic value in..